Phase II study of weekly gemcitabine in advanced non-small cell lung cancer

Respiratory Medicine

Volumn 91, Issue 7, 1997, Pages 423-426

  Halme, M ^a   Jekunen, A ^b   Tamminen, K ^b   Mattson, K ^a  

^a Div Pulmon Dis Clin Physiol   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; NUCLEOSIDE ANALOG;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; EDEMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; THROMBOCYTOPENIA; TIME;

EID: 0030816630     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90257-2     Document Type: Article

References (11)

1. Belani CP, Aisner J. Combined-modality therapies for non-small cell lung cancer. Ann Oncol 1992; 3 (Suppl. 3): 3-10.
2. Vrdoljak E, Mise K, Sapunar D et al. Survival analysis of untreated patients with non-small-cell lung cancer. Chest 1994; 106: 1797-1800.
3. Souquet PJ, Chauvin F, Boissel JP et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.
4. Stewart LA and Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trails. Br Med J 1995; 311: 899-909.
5. Lilenbaum RC, Green MR. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 1993; 11: 1391-1402.
6. Carney DN. Management (chemotherapy/best supportive care) of advanced-stage non-small cell lung cancer. Semin Oncol 1995; 22 (Suppl.): 58-62.
7. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
8. Anderson H, Lund B, Bach F et al. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 1994; 12: 1821-1826.
9. Anderson H, Thatcher N, Walling J et al. Gemcitabine, performance status and symptom palliation in non-small cell lung cancer (NSCLC). Eur Respir J 1995; 8 (Suppl. 19): 134.
10. Abratt RP, Bezwoda WR, Falkson G et al. Efficacy and safety profile of gemcitabine in non-small cell lung cancer: a phase II study. J Clin Oncol 1994; 12: 1535-1540.
11. Gatzemeier U, Shepherd FA, Le Chevalier T et al. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer 1996; 32A: 243-238.